You are here

Article Text

Article menu

Download PDFPDF

Letter
Are my patients with rheumatic diseases at higher risk of COVID-19?
Free
  1. Gabriel Figueroa-Parra1,
  2. Gloria Mayela Aguirre-Garcia2,
  3. Carmen Magdalena Gamboa-Alonso1,
  4. Adrian Camacho-Ortiz2,
  5. Dionicio Angel Galarza-Delgado1
  1. 1 Servicio de Reumatología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico
  2. 2 Servicio de Infectología, Hospital Universitario "Dr José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico
  1. Correspondence to Dionicio Angel Galarza-Delgado, Servicio de Reumatología, Hospital Universitario Dr Jose Eleuterio Gonzalez, 64460 Monterrey, Mexico; dgalarza{at}medicinauanl.mx

https://doi.org/10.1136/annrheumdis-2020-217322

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    According to the last WHO situation report (10 March 2020), the novel Coronavirus disease 2019 (COVID-19) has been confirmed in 113 702 patients, most of them in China (71.1%) and the rest in other 109 countries, with a global case-fatality rate (CFR) of 3.5% (4012 deaths among 113 702 confirmed cases).1 Most patients have presented with fever, dry cough and fatigue, about 81% of cases reported in China have been classified as mild, 14% severe and 5% critical, the higher CFR has been observed among older patients and with comorbid conditions (cardiovascular disease, diabetes, chronic respiratory disease, hypertension, cancer, etc).2 To our knowledge none of the fatal cases reported has been associated with rheumatic diseases.

    Patients with rheumatic diseases are …

    View Full Text